These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1801)

  • 21. Inhibition by L-prolyl-L-leucyl-glycinamide (PLG) of alpha-melanocyte stimulating hormone release from hypothalamic slices.
    Scimonelli T; Celis ME
    Peptides; 1982; 3(6):885-9. PubMed ID: 6132363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological effects of MIF-1, MSH, and opiate peptides in clinical studies.
    Kastin AJ; Ehrensing RH; Olson RD; Coy DH
    Int J Neurol; 1980; 14(2-4):205-9. PubMed ID: 6152908
    [No Abstract]   [Full Text] [Related]  

  • 23. Appetitive acquisition and extinction effects with exogenous ACTH.
    Guth S; Levine S; Seward JP
    Physiol Behav; 1971 Aug; 7(2):195-200. PubMed ID: 4337408
    [No Abstract]   [Full Text] [Related]  

  • 24. alpha-MSH and Pro-Leu-Gly-NH2 (PLG; MIF-1): influence on dopamine (DA) uptake in crude synaptosomal preparations from rat mediobasal hypothalamus (MBH) and caudate putamen (CP).
    Torre E; Celis ME; Chiocchio SR
    Peptides; 1984; 5(4):669-74. PubMed ID: 6149522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Functional state of the sympathetic-adrenal system in melanocyte-stimulating hormone deficiency under the effect of the melanocyte-inhibiting factor of the hypothalamus].
    Mel'nik BE; Robu AI; Paladiĭ ES
    Probl Endokrinol (Mosk); 1980; 26(2):57-60. PubMed ID: 6103533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menalocyte stimulating hormone and MSH/ACTH4-10 reduce tonic immobility in the lizard.
    Stratton LO; Kastin AJ
    Physiol Behav; 1976 Jun; 16(6):771-4. PubMed ID: 10593
    [No Abstract]   [Full Text] [Related]  

  • 27. New evidence that demonstrates that L-pro-L-leu-L-gly-NH2 might be the natural MIF.
    Vivas A; Celis ME
    Acta Physiol Lat Am; 1977; 27(4):177-82. PubMed ID: 31762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enkephalin and a potent analog facilitate maze performance after intraperitoneal administration in rats.
    Kastin AJ; Scollan EL; King MG; Schally AV; Coy DH
    Pharmacol Biochem Behav; 1976 Dec; 5(6):691-5. PubMed ID: 1023235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of MIF-I, beta-endorphin and alpha-MSH on d-amphetamine induced paradoxical behavioral thermoregulation: possible involvement of the dopaminergic system.
    Yehuda S; Sheleff P
    Peptides; 1985; 6(2):189-92. PubMed ID: 2863810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MIF-1 can accelerate neuromotor, EEG and behavioral development in mice.
    d'Amore A; Pieretti S; Palazzesi S; Pezzini G; Chiarotti F; Scorza T; Loizzo A
    Peptides; 1990; 11(3):527-32. PubMed ID: 1974348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.
    Mycroft FJ; Wei ET
    Peptides; 1984; 5(5):883-7. PubMed ID: 6150468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The influence of MIF (melanocyte-stimulating hormone-release inhibiting factor) on psychomotor function and mood in parkinsonian patients. Preliminary report (author's transl)].
    Schneider E; Fischer PA; Jacobi P; Reh W
    Arzneimittelforschung; 1978; 28(8):1296-7. PubMed ID: 37848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CNS and pituitary effects of hypothalamic peptides and MSH.
    Kastin AJ; Miller LH; Sandman CA; Schally AV; Plotnikoff NP
    Essays Neurochem Neuropharmacol; 1977; 1():139-76. PubMed ID: 30623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptides and thermoregulation.
    Yehuda S; Kastin AJ
    Neurosci Biobehav Rev; 1980; 4(4):459-71. PubMed ID: 6110198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular mechanisms controlling melanophore stimulating hormone (MSH) release.
    Hadley ME; Hruby VJ; Bower A
    Gen Comp Endocrinol; 1975 May; 26(1):24-35. PubMed ID: 236974
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of prolyl-leucyl-glycinamide and alpha-melanocyte-stimulating hormone on levorphanol-induced analgesia, tolerance and dependence.
    Contreras PC; Takemori AE
    Life Sci; 1984 Jun; 34(26):2559-66. PubMed ID: 6146083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurologically active peptides.
    Barbeau A; Gonce M; Kastin AJ
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):159-63. PubMed ID: 13415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-melanocyte stimulating hormone facilitates learning of visual but not auditory discriminations.
    Handelmann GE; O'Donohue TL; Forrester D; Cook W
    Peptides; 1983; 4(2):145-8. PubMed ID: 6622283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of MSH and related peptides on avoidance behavior in rats.
    Wimersma Greidanus TB
    Front Horm Res; 1977; 4():129-39. PubMed ID: 207591
    [No Abstract]   [Full Text] [Related]  

  • 40. Pineal vasotocin: release into cat cerebrospinal fluid by melanocyte-stimulating hormone release-inhibiting factor.
    Pavel S; Goldstein R; Gheorghiu C; Calb M
    Science; 1977 Jul; 197(4299):178-9. PubMed ID: 17916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.